/
BNKL
$0.00-$0.00 (-99.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-0.80
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $571.9K | $987.4K | $3.2M | $2.2M | $1.2M | $1.3M | $1.8M |
| Cost of revenue | $63.5K | $388.8K | $402.7K | $1.6M | $893.4K | $269.6K | $320.5K | $815.3K |
| Gross profit | −$63.5K | $183.2K | $584.8K | $1.6M | $1.3M | $923.8K | $953.3K | $989.9K |
| Gross margin | — | 32.0% | 59.2% | 49.8% | 58.5% | 77.4% | 74.8% | 54.8% |
| R&D | $1.4M | $2.7M | $2.8M | $3.2M | $3.9M | $1.5M | $998.5K | $903.2K |
| Operating income | −$6.6M | −$8.0M | −$10.0M | −$7.3M | −$11.2M | −$6.2M | −$4.8M | −$4.8M |
| EBITDA | −$6.6M | −$7.4M | −$9.7M | −$6.9M | −$24.5M | −$13.0M | −$9.5M | −$4.8M |
| Net income | $1.0M | −$3.9M | −$14.7M | −$10.6M | −$24.9M | −$13.6M | −$10.4M | −$4.9M |
| Net margin | — | -688.3% | -1491.6% | -325.2% | -1157.9% | -1141.3% | -817.1% | -274.0% |
| EPS (diluted) | 1.94 | -6.43 | -21.88 | -4.47 | -5.60 | -2.66 | -1.78 | -0.72 |
Annual figures · source: Financial Modeling Prep
Peer comparison
BIONIK LABORATORIES CORP
BIONIK LABORATORIES CORP
Held by traders on TradeandTell
No one on the platform currently holds BNKL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BNKL as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2018-10-30 | 1-for-150reverse |
Recent trades on TradeandTell
No one on the platform has traded BNKL yet.